Profile data is unavailable for this security.
About the company
Indoco Remedies Limited is an India-based manufacturer of pharmaceutical products. The Company is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs). The Company offers medicines in multiple therapeutic categories, such as diabetology, respiratory, stomatology, women's health, nutritional products, gastroenterology, cardiology, metabolic disorders and primary care medicine. Its products/brands include Cyclopam, Sensodent-K, Karvol Plus, Sensoform, Cital UTI, Kidodent, Rexidin M, Lignox A, Dentogel, Aloja, Homide, Renolen, Noxa, Dexoren - S, Aloja M, ATM, Febrex Plus, Sensodent-KF, SM Fibro, MCBM 69, Cal Aid, Snowdent, Dropizin, Zincoren, Coloferrin, Bfloren, RR Sensoform Dental, Mofloren-D, and Tuspel among others. The Company caters to both domestic and international markets. Its subsidiaries include Xtend Industrial Designers and Engineers Pvt Ltd, Indoco Remedies Czech sro, and Indoco Remedies UK Limited.
- Revenue in INR (TTM)18.17bn
- Net income in INR984.70m
- Incorporated1947
- Employees6.10k
- LocationIndoco Remedies Ltd166 Indoco HouseCst Road, Santacruz EastMUMBAI 400098IndiaIND
- Phone+91 2 226541851
- Fax+91 2 226523980
- Websitehttps://www.indoco.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SMS Pharmaceuticals Ltd | 7.09bn | 498.26m | 21.70bn | 1.10k | 43.53 | 4.05 | 26.89 | 3.06 | 5.89 | 5.89 | 83.84 | 63.36 | 0.7413 | 2.18 | 3.69 | -- | 5.14 | 5.43 | 7.41 | 7.33 | 29.83 | 32.67 | 6.94 | 7.87 | 0.905 | 3.63 | 0.3436 | 6.59 | 35.86 | 8.81 | 805.82 | 4.47 | 8.41 | 9.86 |
| Hester Biosciences Ltd | 3.05bn | 188.89m | 21.91bn | 693.00 | 103.46 | 7.51 | 57.14 | 7.19 | 24.89 | 24.89 | 392.38 | 343.01 | 0.4572 | 1.20 | 3.85 | -- | 3.18 | 6.15 | 4.00 | 7.69 | 68.52 | 68.83 | 6.95 | 12.83 | 1.31 | 1.84 | 0.4466 | 23.27 | 14.45 | 11.33 | -29.06 | -14.59 | 1.49 | -11.42 |
| IOL Chemicals and Pharmaceuticals Ltd. | 21.33bn | 1.34bn | 23.64bn | 2.56k | 17.59 | 1.47 | 11.98 | 1.11 | 22.90 | 22.90 | 363.33 | 274.49 | 0.9998 | 3.72 | 4.37 | -- | 6.30 | 14.91 | 8.27 | 19.45 | 34.50 | 34.79 | 6.30 | 12.00 | 1.24 | 10.41 | 0.0199 | -- | -3.80 | 4.82 | -3.39 | -10.70 | 35.27 | -- |
| Solara Active Pharma Sciences Ltd | 13.26bn | -5.67bn | 24.12bn | 2.36k | -- | 2.41 | -- | 1.82 | -145.25 | -145.25 | 339.41 | 239.08 | 0.505 | 1.75 | 2.99 | -- | -21.60 | -2.44 | -39.08 | -3.84 | 39.28 | 43.38 | -42.77 | -4.49 | 0.3549 | -1.89 | 0.5192 | -- | -10.73 | -1.45 | -2,458.12 | -- | -4.81 | -- |
| Dishman Carbogen Amcis Ltd | 26.16bn | -1.53bn | 24.94bn | 1.30k | -- | 0.4432 | 15.84 | 0.9535 | -9.79 | -9.79 | 166.66 | 358.94 | 0.2748 | 0.7081 | 4.98 | -- | -1.61 | -0.3986 | -2.09 | -0.4888 | 77.17 | 74.89 | -5.87 | -1.54 | 0.4092 | -0.1265 | 0.2913 | -- | 8.41 | 4.91 | -414.93 | -- | -0.3175 | -- |
| Jeena Sikho Lifecare Ltd | -100.00bn | -100.00bn | 26.10bn | 1.23k | -- | 82.56 | -- | -- | -- | -- | -- | 12.72 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.8228 | -- | 0.2681 | -- | 43.84 | -- | 77.37 | -- | -- | -- |
| Morepen Laboratories Ltd | 16.90bn | 961.60m | 28.19bn | 1.65k | 29.34 | 3.33 | 21.67 | 1.67 | 1.88 | 1.88 | 33.11 | 16.58 | 1.41 | 4.45 | 5.74 | -- | 8.04 | 7.90 | 11.50 | 13.34 | 37.15 | 33.65 | 5.72 | 5.49 | 1.59 | 33.73 | 0.0331 | -- | 19.25 | 17.08 | 148.63 | 27.22 | 47.03 | -- |
| Indoco Remedies Ltd | 18.17bn | 984.70m | 30.04bn | 6.10k | 30.98 | 2.71 | 15.91 | 1.65 | 10.52 | 10.52 | 193.15 | 120.38 | 0.9557 | 1.65 | 4.80 | -- | 5.10 | 6.88 | 7.02 | 9.85 | 69.23 | 66.66 | 5.34 | 6.93 | 0.9825 | 4.01 | 0.377 | 12.67 | 8.91 | 13.41 | -30.78 | -- | 34.54 | 37.97 |
| RPG Life Sciences Limited | 6.00bn | 923.20m | 30.58bn | 1.27k | 33.12 | -- | 27.68 | 5.10 | 55.82 | 55.82 | 362.60 | -- | -- | -- | -- | 4,721,969.00 | -- | 16.07 | -- | 21.77 | 68.42 | 62.99 | 15.39 | 11.99 | -- | 220.43 | -- | 29.27 | 13.50 | 12.01 | 29.60 | 51.98 | 28.60 | 46.14 |
| Supriya Lifescience Ltd | 5.70bn | 1.19bn | 30.59bn | 392.00 | 25.68 | 3.75 | 22.67 | 5.36 | 14.80 | 14.80 | 70.87 | 101.31 | 0.655 | 2.21 | 5.81 | -- | 13.68 | 19.08 | 15.19 | 24.04 | 61.12 | 58.71 | 20.88 | 24.71 | 4.06 | 66.40 | 0.0067 | 2.88 | 23.74 | 15.47 | 32.56 | 24.75 | 83.79 | -- |
| Innova Captab Ltd | 10.81bn | 943.45m | 32.16bn | -- | 25.30 | 3.87 | 29.15 | 2.97 | 22.21 | 22.21 | 235.31 | 145.20 | -- | -- | -- | -- | -- | 10.82 | -- | 18.38 | 32.64 | 25.18 | 8.73 | 8.04 | 1.64 | 6.45 | 0.2278 | -- | 16.72 | 24.90 | 38.84 | 36.55 | 104.14 | -- |
| Gufic BioSciences Ltd | 8.07bn | 861.36m | 34.26bn | 1.63k | 39.05 | 6.43 | 33.21 | 4.25 | 8.75 | 8.75 | 81.90 | 53.11 | 0.8258 | 2.03 | 3.01 | -- | 8.82 | 11.46 | 13.32 | 19.21 | 51.67 | 46.99 | 10.68 | 10.46 | 1.08 | 8.37 | 0.3847 | -- | 16.80 | 18.12 | 8.07 | 31.46 | 53.83 | 14.87 |
| SeQuent Scientific Ltd | 13.70bn | -358.69m | 36.08bn | 478.00 | -- | 5.49 | 113.02 | 2.63 | -1.45 | -1.45 | 56.27 | 26.37 | 0.8925 | 2.19 | 4.05 | -- | -1.93 | 1.09 | -3.27 | 1.76 | 44.53 | 42.74 | -2.16 | 1.18 | 0.7602 | 0.1376 | 0.4062 | -- | -3.60 | 5.68 | 70.40 | -- | 6.96 | -- |
| Unichem Laboratories Ltd | 17.05bn | -704.74m | 37.01bn | 3.19k | -- | 1.57 | 86.53 | 2.17 | -9.99 | -9.99 | 238.80 | 335.54 | 0.5359 | 0.9909 | 2.84 | 5,337,805.00 | -2.22 | -1.67 | -2.81 | -2.03 | 61.02 | 56.18 | -4.13 | -3.99 | 1.39 | -0.5733 | 0.0948 | -- | 26.94 | 7.64 | 65.15 | -- | -35.00 | -- |
Data as of Jul 23 2024. Currency figures normalised to Indoco Remedies Ltd's reporting currency: Indian Rupee INR
17.71%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Nippon Life India Asset Management Ltd. (Invt Mgmt)as of 30 Jun 2024 | 4.58m | 4.97% |
| quant Money Managers Ltd.as of 28 Jun 2024 | 4.20m | 4.56% |
| DSP Asset Managers Pvt. Ltd.as of 30 Jun 2024 | 2.09m | 2.27% |
| ICICI Prudential Asset Management Co. Ltd.as of 30 Jun 2024 | 1.65m | 1.79% |
| Franklin Templeton Asset Management (India) Pvt Ltd.as of 28 Jun 2024 | 1.36m | 1.48% |
| HDFC Asset Management Co. Ltd. (Invt Mgmt)as of 30 Jun 2024 | 1.33m | 1.45% |
| Dimensional Fund Advisors LPas of 04 Jul 2024 | 511.50k | 0.56% |
| Tata Asset Management Pvt Ltd.as of 30 Jun 2024 | 276.85k | 0.30% |
| Fiduciary Management, Inc.as of 30 Jun 2024 | 165.42k | 0.18% |
| UTI Asset Management Co. Ltd. (Investment Management)as of 30 Jun 2024 | 154.59k | 0.17% |
More ▼
Data from 31 Mar 2024 - 18 Jul 2024Source: FactSet Research Systems Inc.
